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Abstract: The effect of resistance exercise with the ingestion of supplementary protein on 
the activation of the mTOR cascade, in human skeletal muscle has not been fully 
elucidated. In this study, the impact of a single bout of resistance exercise, immediately 
followed by a single dose of whey protein isolate (WPI) or placebo supplement, on the 
activation of mTOR signalling was analyzed. Young untrained men completed a maximal 
single-legged knee extension exercise bout and were randomized to ingest either WPI 
supplement (n = 7) or the placebo (n = 7). Muscle biopsies were taken from the vastus 
lateralis before, and 2, 4 and 24 h post-exercise. WPI or placebo ingestion consumed 
immediately post-exercise had no impact on the phosphorylation of Akt (Ser
473). However, 
WPI significantly enhanced phosphorylation of mTOR (Ser
2448), 4E-BP1 (Thr
37/46) and 
p70
S6K (Thr
389) at 2 h post-exercise. This study demonstrates that a single dose of WPI, 
when consumed in modest quantities, taken immediately after resistance exercise elicits an 
acute and transient activation of translation initiation within the exercised skeletal muscle.    
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1. Introduction 
 
Resistance exercise is a potent stimulus of muscle hypertrophy, with net increases in skeletal 
muscle protein synthesis persisting during recovery [1,2]. Necessary for the enhanced rate of protein 
synthesis is the activation of kinases in the IGF-1/Akt/mTOR pathway [3,4]. mTOR exerts a critical 
role in mediating the signaling necessary for mRNA translation initiation, an important regulatory site 
in cellular protein synthesis [5]. Key targets for mTOR activation include the 70-kDa ribosomal 
protein S6 kinase (p70
S6K) and the eukaryotic initiation factor 4E-binding protein (4E-BP1). Both are 
crucial in stimulating downstream effectors in the activation of the ribosomal subunits and the 
maintenance of translation for 5’-terminal polypyrimidine (TOP sequences) mRNA’s, that encode 
many ribosomal proteins and translation factors integral to accommodate demands of increased   
protein synthesis.  
The activation of translation initiation following acute resistance exercise in the absence of nutrient 
ingestion is minimal [6,7]. However, both the activation of skeletal muscle protein synthesis and 
translation initiation is markedly enhanced with the ingestion of essential amino acids. The activation 
of translation initiation by amino acids is independent of upstream components of IGF-1 signalling, 
with mTOR acting as a convergence point for the separate actions of amino acids and resistance 
exercise [5,8]. Thus evidence has accumulated such that when a resistance exercise stimuli is 
combined with a large ingested dose of amino acids, there is synergistic activation of mTOR and 
downstream kinases necessary for translation initiation [6,7]. In these studies, branch-chain amino 
acids (BCAA; total dose 100 g) consumed prior, during and in the early recovery phase, resulted in 
markedly greater mTOR, p70
S6K and rpS6 phosphorylation, than was observed with exercise alone.  
The actions of amino acids to potentiate protein synthesis in the recovery period after exercise also 
extend to the ingestion of whole protein sources, including the dairy proteins casein and whey [9]. 
Whey proteins are a common source for supplemental amino acids used by body-builders and strength 
training athletes, yet few studies have addressed whether the ingestion of a dose of whey protein in 
quantities normally consumed by strength training athletes is effective in activating the key kinase 
involved in translation initiation [10,11]. Doses of 20 grams of whey protein ingested either 
immediately prior to or following a single bout of resistant exercise have been previously reported to 
enhance the rate of protein synthesis [12]. Thus, the present study aimed to measure the 
phosphorylation status of Akt, mTOR, 4E-BP1, p70
S6K and rpS6 in human skeletal muscle following 
either a single bout of resistance exercise alone (placebo) or when supplemented with a comparable 
dose of whey protein isolate (WPI).  
2. Results and Discussion 
2.1. Resistance Exercise  
 
Participant characteristics are shown in Table 1. All subjects performed three sets of 12 repetitions 
of maximal knee extension on the Cybex machine. The groups were matched for age, BMI and   
leg strength.  
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Table 1. Subject characteristics and Peak Torque. 
         Placebo                    WPI 
   (n = 7)  (n = 7) 
Age, yr  23.0 ± 0.9  21.9 ± 0.8 
Height, cm  178.0 ± 3.5  176.7 ± 2.7 
Mass, kg  76.7 ± 4.5  76.2 ± 2.8 
BMI, kg·m
2  24.1 ± 0.1  24.5 ± 1.1 
Peak Torque (Nm)    
Concentric  212.3 ± 13.3  213.1 ± 10.9 
Eccentric  260.7 ± 16.2  255.7 ±  9.9 
 
2.2. Amino Acid Analysis of Supplements 
 
As BCAA have been identified as potent promoters of protein synthesis above other amino acids, 
the BCAA composition of the WPI is reported in Table 2. BCAA comprised 25% of the total amino 
acids measured and specifically leucine contributed 14% of the total amino acids consumed by the 
WPI group. No amino acids were detected in the placebo supplement.  
Table 2 Amino acid composition of WPI drink. 
Amino acid  
g / 200 mL 
WPI drink      
Essential amino acids   
Histidine 0.56 
Isoleucine 1.49 
Lysine 2.87 
Methionine 0.71 
Phenylalanine 0.93 
Threonine 1.30 
Leucine 3.66 
Valine 1.41 
Nonessential amino acids   
Alanine 1.57 
Arginine 0.73 
Aspartate 2.94 
Glutamate 4.80 
Glycine 0.39 
Proline 1.30 
Serine 1.01 
Tyrosine 0.95 
Total Amino Acids (g)  26.6 
Total BCAA  6.6 
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2.3. Kinase Analysis 
 
A single bout of maximal knee extension exercise, immediately proceeded by either WPI or placebo 
ingestion had no impact on the phosphorylation of Akt at Ser
473 (Figure 1). In contrast, 2 h following 
WPI ingestion, mTOR demonstrated enhanced phosphorylation at the Ser
2448 site (2.1-fold change). 
Figure 1 Phosphorylation of Akt at Ser
473 in human skeletal muscle at rest and 2, 4 and 24 
h post-exercise during placebo and WPI trials.  Values are arbitrary units (mean ± SEM;  
n = 7 per trial).Open bars represent placebo, closed bars represent WPI.  
 
Figure 2 Phosphorylation of mTOR at Ser
2448 in human skeletal muscle at rest and 2, 4 and 
24 h post-exercise during placebo and WPI trials. Values are arbitrary units   
(mean ± SEM; n=7 per trial). Open bars represent placebo, closed bars represent WPI.  
*P < 0.05 vs. resting values. 
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There was a rise in mTOR Ser
2448 4 h following the ingestion of the placebo, though this failed to 
achieve significance (Figure 2). Of the possible downstream targets of mTOR, the phosphorylation of 
4E-BP1 at Thr
37/46 was significantly increased 3.0-fold  above resting values by WPI ingestion   
(Figure 3).  
Figure 3 Phosphorylation of 4E-BP1 at Thr
37/46 in human skeletal muscle at rest and 2, 4 
and 24 h post-exercise during placebo and WPI trials. Values are arbitrary units   
(mean ± SEM; n=7 per trial). Open bars represent placebo, closed bars represent WPI.  
**P < 0.01 vs. resting values.       
 
 
Figure 4 Phosphorylation of p70
S6K at Thr
389 in human skeletal muscle at rest and 2, 4 and 
24 h post-exercise during placebo and WPI trials. Values are arbitrary units   
(mean ± SEM; n = 7 per trial). Open bars represent placebo, closed bars represent WPI. 
***P < 0.001 vs. resting values.       
 Nutrients 2009, 1                                       
 
 
268
An alternative substrate for mTOR, p70
S6K was highly phosphorylated in response to WPI 
ingestion at 2 h recovery, increasing 6.2-fold (Figure 4). In turn rpS6, the downstream substrate of 
p70
S6K, displayed high within-subject variability and failed to achieve significant changes at any time 
point (Figure 5).  
Figure 5 Phosphorylation of rpS6 at Ser
235/236 in human skeletal muscle at rest and 2, 4 and 
24 h post-exercise during placebo and WPI trials. Values are arbitrary units   
(mean ± SEM; n = 7 per trial). Open bars represent placebo, closed bars represent WPI.  
 
This study demonstrates the stimulatory effect of WPI supplementation on the activation of 
regulators of translational initiation, the key step in the commencement of cellular protein synthesis, 
following a single bout of resistance exercise. Ingestion of WPI (26.6 g) immediately at the completion 
of a single bout of strenuous leg resistance exercise, induced a greater response in the phosphorylation 
of mTOR, p70
S6K and 4E-BP1, compared to exercise plus placebo ingestion. The heightened 
responsiveness of these kinases was rapid, predominately occurring within 2 h of exercise completion. 
Furthermore, there was no evidence for a persistence of this beneficial action for WPI, at both 4 and  
24 h following the exercise.  
Resistance exercise provokes muscle hypertrophy through a number of purported signal 
transduction pathways, including activation of the PI(3)K/Akt pathway [13]. This is evident in both rat 
and in vitro studies [3,14,15]. Akt is a serine/threonine kinase involved in the regulation of cellular 
metabolism and has been shown to induce rapid skeletal muscle hypertrophy in vivo [16]. 
Phosphorylation of Ser
473 is required for maximal activation of Akt and it appears that Akt may have a 
relatively short activation period after an acute bout of resistance exercise [17,18]. Human studies 
investigating the activation of Akt after resistance exercise are scarce and have shown an enhanced 
phosphorylation of Akt 1 h post-exercise, but not immediately after exercise [19,20]. Indeed, the 
supplementary ingestion of 100 g BCAA and exercise combined has been reported to induce a small, 
albeit significant, increase in Akt activation at 1 hr post-exercise [7]. In the current study, Ser
473 
phosphorylation of Akt was unaltered following either exercise or exercise combined with 26.6 g WPI 
ingestion at any of the measured time points.  Nutrients 2009, 1                                       
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mTOR is a 289 kDa serine/threonine kinase partially downstream of Akt and responsible for the 
complex integration of anabolic stimuli mediating cell growth. Chiefly, mTOR stimulates protein 
synthesis through downstream activation of p70
S6K and 4E-BP1, providing a key point of convergence 
for both resistance exercise and amino acids [5,8]. WPI ingestion significantly increased Ser
2448 
phosphorylation of mTOR 2 h post-exercise. Interestingly, the ingestion of 100 g BCAA as previously 
reported, prompted an increase in mTOR phosphorylation at 1 h post-exercise, but failed to persist to  
2 h recovery [7]. Both leucine and Akt activate mTOR through phosphorylation of the Ser
2448  
site [8,21]. Amino acids have been described as “priming” molecules, whose phosphorylation of 
mTOR at Ser
2448 is a prerequisite for further phosphorylation by Akt [22]. Furthermore, activation of 
mTOR can occur through two separate signalling pathways by either insulin induced activation of the 
PI(3)K/Akt pathway or an undefined Akt-independent pathway stimulated by amino acids [23-25]. 
One possible candidate is Vps34 (vacuolar protein sorting mutant 34), a class III PI3K 
(phosphoinositide 3-kinase), regulated by both resistance exercise and nutrient availability [26]. 
However the interaction between supplementary protein ingestion and resistance exercise on the 
regulation of Vps34 is not yet described. 
Downstream of mTOR, activation of p70
S6K is strongly linked to muscle hypertrophy [27]. p70
S6K 
undergoes phosphorylation at multiple serine and threonine residues, with the Thr
389 residue closely 
associated with complete activation of the kinase [28]. The acute resistance exercise bout performed 
by the placebo group was not sufficient to induce phosphorylation of p70
S6K during the time points 
measured. The provision of whey proteins in this study stimulated an early and robust activation of 
p70
S6K. These findings are consistent with those reported previously, in which BCAA ingestion 
increases phosphorylation of p70
S6K at Thr
389 2 h post-exercise [6]. Further scrutiny of these results 
revealed that the magnitude of response was far greater (approximately double) in this earlier trial. 
This may be due to the large 100 g dose of BCAA ingested, compared to 26.6 g of whey proteins 
administered in the current study. A dose-response of increasing leucine ingestion to increasing p70
S6K 
(Thr
389) phosphorylation was observed in rats [29]. Moreover, it is suggested that full activation of 
p70
S6K is dependent on the provision of amino acids to elicit a downstream activation of rpS6 [6,30]. 
Thus, a modest dose of 26.6 g WPI taken in conjunction with a single bout of resistance exercise 
clearly changed the signalling response of p70
S6K, although larger doses of WPI may be required to 
have a downstream impact on rpS6 during exercise recovery. Exercise plus placebo also resulted in an 
increased, but not significant, phosphorylation of rpS6, however this occurred later in recovery at 4 h. 
It is unknown whether this time differential in rpS6 activation is of physiological relevance.  
In addition to p70
S6K, the phosphorylation of 4E-BP1 is sensitive to amino acid provision [31]. The 
site-specific phosphorylation of Thr
37/46 is reported to be crucial for optimal activation of 4E-BP1  [32]. 
In this study a marked increase in 4E-BP1 phosphorylation at 2 h post-exercise was measured when 
subjects were fed WPI. No change in Thr
37/46 phosphorylation of 4E-BP1 was shown after exercise 
alone. This is consistent with a previous study that not only demonstrated no increase in 4E-BP1 
phosphorylation in human skeletal muscle after an acute resistance bout, but a significant decrease in 
Thr
37/46 phosphorylation was observed immediately and 2 h post-exercise [30].  
Whey proteins are a rich source of leucine (14%) and BCAA (26%) [33]. Previously our group has 
demonstrates that this modest dose (26.6g) WPI elicits a rapid rise in plasma amino acids, peaking 
around 1 hour following ingestion [34]. Consistent with this data and the demonstration that kinases Nutrients 2009, 1                                       
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central to translation initiation are enhance, data has been reported that the ingestion of supplementary 
WPI, either before or immediately following resistance exercise training enhances both muscularity 
and strength gains in young males undertaking resistance training programs [35-37]. In supporting 
these studies, our data provides cellular evidence of the efficacy of combined WPI ingestion and 
resistance exercise to activate translation initiation. Indeed, when consumed immediately at exercise 
cessation, a modest 26.6 g WPI induced a more rapid and heightened activation of three kinases, 
mTOR, 4E-BP1 and p70
S6K at 2 h recovery. This has important implications for athletes, as this dose 
can be readily incorporated into a variety of either beverage (as used in the current study) or food 
formulations. Future research must then be directed towards examining the chronic actions on either 
muscular mass or strength with equivalent doses of whey protein.  
 
3. Experimental Section  
 
3.1. Subjects 
 
Fourteen healthy young men (aged 18–25 yr) who had not participated in regular resistance exercise 
within a year prior to commencing the study and were not currently using nutritional or other 
purported muscle building supplements were recruited. A medical history questionnaire was used to 
exclude subjects with a diagnosed condition or illness that would endanger subjects during strenuous 
exercise. All subjects were informed of the nature and possible risks of the experimental procedures, 
before their written informed consent was obtained. This study and all associated procedures was 
formally approved by the Deakin University Human Research Ethics Committee.  
 
3.2. Nutritional Composition of Supplement Drinks  
 
Subjects were randomly assigned to receive either a whey protein isolate (WPI) or placebo drink. 
The WPI powder contained 97% protein powder (of which 90% protein, 0.5% fat, 0.5% lactose, 5% 
moisture, 3.7% ash and 1.15% milk minerals), 2.9% artificial flavour and 0.1% aspartame sweetener, 
with a dose of 28.65 g powder prepared in 200 mL water (this dose delivered 26.6g protein per 200 
mL, see Table 2). The protein powder component was a β-lactoglobulin-enriched whey protein isolate 
(WPI: NatraBoost
® BLG, Murray Goulburn Nutritionals, Brunswick, Victoria, Australia). The placebo 
powder was prepared in the same volume and contained the same quantity of artificial flavour and 
aspartame sweetener and both drinks looked identical.  
 
3.3. Amino Acid Analysis of Supplement Drinks 
 
The WPI and placebo supplements were analysed for amino acid composition as described 
previously [38]. Briefly, samples were hydrolysed in 6 M HCl to determine total amino acids 
(excluding tryptophan, cysteine, asparagine and glutamine). The hydrolysates were rotary evaporated 
to dryness to remove the HCl and reconstituted in sodium citrate buffer (pH 2.2), including internal 
standard norleucine. Samples were then run on HPLC (Water Inc.; Empower Pro, Version 2, Software, Nutrients 2009, 1                                       
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Waters Corporation) and amino acids were separated by ion-exchange column (Sodium, Part# 
WAT08002, Waters, USA) and detected by UV after a post-column ninhydrin reaction.   
 
3.4. Experimental Design 
 
At least four days prior to the testing day, each subject completed a familiarization session on the 
Cybex NORM dynamometer (Cybex International Inc. UK). For the 24 h preceding, and the days of 
the trial, subjects consumed a standard controlled diet of 20% fat, 14% protein and 66% carbohydrate 
and abstained from alcohol, caffeine, tobacco and recreational exercise. Following an overnight fast, 
subjects reported to the exercise physiology laboratory for a resting muscle biopsy. Thirty minutes 
after the biopsy subjects completed three sets of 12 repetitions of maximal singled-legged knee 
extension exercise on the Cybex machine with a 2 minute rest between each set. Each repetition 
involved concentric and eccentric contraction of the knee extensors at a set speed of 60°/sec on the 
biopsied leg. Subjects were instructed to contract as hard as possible and were verbally encouraged 
throughout each set. On completion of the exercise, subjects immediately ingested the supplement and 
were required to remain resting in the laboratory for biopsies to be taken 2 h and 4 h post-exercise. 
Subjects were supplied with lunch and an evening meal to eliminate bias from their post-exercise meal 
and given instructions to avoid caffeine, dairy products and high protein foods (including eggs, 
chicken, fish and red meat). Subjects then returned to the laboratory the following morning following 
an overnight fast for a biopsy 24 h post-exercise. Needle biopsies were performed in the vastus 
lateralis muscle of the non-dominant leg, under aseptic conditions following local anesthesia (1% 
xylocaine). Excised muscle tissue from each biopsy was immediately frozen and stored in liquid 
nitrogen for subsequent analysis. To minimize the potential or interference of repeated biopsies, 
samples were collected at least 2 cm from previous biopsy sites.  
 
3.5. Tissue Processing 
 
Muscle samples (~30 mg) were homogenized in ice cold lysis buffer containing 20 mM Tris-HCL, 
5 mM EDTA, 10 mM Na-pyrophosphate, 100 mM NaF, 2 mM Na3VO4, 1% igepal, 10 μg/mL 
aprotinin, 10 μg/mL leupeptin, 3 mM benzamidine and 1 mM PMSF. Homogenates were rotated on ice 
for 1 h and then centrifuged at 13,000 x g for 10 min. The resulting supernatant was analyzed for total 
protein content using the BCA protein assay (Pierce Biotechnology, Inc. Rockford, IL).  
 
3.6. Immunoblot Analysis 
 
Denatured total proteins from each sample in loading buffer were separated by electrophoresis by 
5% (phospho-mTOR), 8% (phospho-Akt, phospho-p70
S6K) or 12% (phospho-4E-BP1, phospho-S6) 
SDS-PAGE and transferred to nitrocellulose membranes, or PVDF for phospho-4E-BP1 and phospho-
S6. PVDF membranes were blocked by air drying and nitrocellulose membranes were blocked with 
5% bovine-serum albumin in Tris-buffered saline for 1 h (phospho-mTOR) or 2 h (phospho-Akt, 
phospho-p70
S6K). All membranes were incubated overnight at 4°C with polyclonal rabbit anti-
phospho-mTOR (Ser
2448), phospho-p70
S6K (Thr
389), phospho-S6 ribosomal protein (Ser
235/236), Nutrients 2009, 1                                       
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phospho-4E-PB1 (Thr
37/46) and phospho-Akt (Ser
473) antibodies at 1:1,000 dilution (all from Cell 
Signaling Technology, Danvers, MA). Membranes were washed in TBST followed by 60 min 
incubation with anti-rabbit IgG conjugated to horse-radish peroxidase (Santa Cruz Biotechnology, 
Santa Cruz, CA) then washed again. Immunoreactive bands were detected using enhanced 
chemiluminescence (Western Lightning Chemiluminescent Reagent, Perkin-Elmer, Boston, MA) and 
visualized on a Kodak Image Station 440CF, using Kodak ID 3.5 image analysis software (Perkin 
Elmer Life Sciences, Boston, MA). 
 
3.7. Statistical Analysis 
 
Statistical analysis was performed using GraphPad Prism 4.1 (GraphPad Software, San Diego, CA). 
Means were compared using two-way ANOVA (repeated measures) and any significant differences 
analyzed using a Bonferroni post hoc test. Data is presented as mean ± standard error of the mean 
(SEM). A probability level of <0.05 was adopted throughout to determine statistical significance 
unless otherwise stated. 
4. Conclusions  
The present study provides evidence that the ingestion of a modest dose of whey protein, taken 
immediately after resistance exercise, is able to enhance the earlier activation of translational kinases 
in young males compared with exercise alone. Further investigations are required to delineate the 
timing, formulation and optimal dosage of WPI to induce maximal translation initiation activation.  
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